GPT and tuberculosis: Previous study by Shu et al demonstrated that the incidence of PZA-related DILI was 3.71 per 100 patient-month, which was more common than the incidence of INH- or RMP-related DILI.[5] Previous study demonstrated that those receiving a PZA-containing regimen had a higher risk of developing DILI.[9] Durand et al described 2 different patterns of DILI in patients receiving anti-TB medication, which a PZA-containing regimen cause a delayed increase of AST and ALT 4 to 8 weeks after initiation of anti-TB therapy.